Marshall Wace’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Marshall Wace's HALO Position: Q2 2026 in Review
Marshall Wace increased its Halozyme (HALO) stake by 56% in Q2 2026, buying an estimated $4.59M and bringing the position to 188,354 shares worth $14.7M. The position accounts for 0.01% of the portfolio, ranked #865.
Marshall Wace first reported a position in HALO in Q1 2019 and has held it in 16 quarters since. The position peaked at $104M in Q3 2023. 670 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Marshall Wace held 188,354 shares of Halozyme worth $14.7M as of Q2 2026.
- Marshall Wace bought 67,348 Halozyme shares in Q2 2026, an estimated $4.59M.
- Halozyme made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #865 holding.
- Marshall Wace first reported a position in Halozyme in Q1 2019 and has held it in 16 quarters since.
- Marshall Wace's Halozyme position peaked at $104M in Q3 2023.
- 670 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.